Risk-based testing is not fewer tests, it is smarter tests
The goal is to concentrate evidence on what could harm product quality, patient safety, or data integrity. Everything else is secondary.
How to build a risk-based test set
1) List critical functions. Workflows that create, modify, approve, or report critical data.
2) Identify failure modes. Wrong calculations, missing approvals, audit trail gaps, integration errors, access misconfiguration.
3) Define controls. Technical and procedural controls that prevent or detect failures.
4) Test controls. Verify the control works, not every screen.
One practical tip
Write tests around decisions. If a workflow leads to approval, release, or record finalization, it deserves deep testing. If not, keep it light and document why.
In recent years, validation processes across the pharmaceutical industry have been undergoing a major transformation. Workflows that were traditionally managed through paper documentation, spreadsheets and manual review cycles are increasingly moving toward digital validation platforms. As a result, life sciences organizations often evaluate solutions such as Kneat, Validfor, ValGenesis, MasterControl and Veeva when modernizing validation lifecycle management and compliance documentation.